Down 1.9% to $27.42, Mylan (NASDAQ:MYL), is one of today's notable movers. The Dow is down 0.4% to 13,089 and the S&P is currently down 0.6% to 1,418.
In the past 52 weeks, Mylan share prices have been bracketed by a low of $15.49 and a high of $28.50 and are now at $27.42, 77% above that low price. The 200-day and 50-day moving averages have moved 0.35% higher and 0.84% higher over the past week, respectively.
Mylan (NASDAQ:MYL) has potential upside of 6.7% based on a current price of $27.42 and analysts' consensus price target of $29.25. The stock should discover initial support at its 50-day moving average (MA) of $26.19 and subsequent support at its 200-day MA of $23.47.
Mylan, Inc. develops, licenses, manufactures, markets, and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients . The Company sells its products to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, group purchasing organizations, and healthcare professionals.